Search clinical trials for: ALKS 5461
Total 300 results
-
Alkermes, Inc.CompletedHepatic ImpairmentUnited States
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Canada, Germany, Puerto Rico, Bulgaria, Australia, Poland, Hungary
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Bulgaria
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Canada, Germany, Puerto Rico
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Australia, Canada
-
Alkermes, Inc.TerminatedRefractory Major Depressive DisorderUnited States, Puerto Rico, Australia
-
Alkermes, Inc.CompletedPharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal FunctionRenal ImpairmentUnited States
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States
-
Alkermes, Inc.CompletedA Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)Major Depressive DisorderUnited States, Canada
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Puerto Rico, Australia
-
Alkermes, Inc.Completed
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
-
Alkermes, Inc.Completed
-
Senhwa Biosciences, Inc.RecruitingAdvanced Solid TumorUnited States, Canada
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
-
Alkermes, Inc.RecruitingNarcolepsy Type 1United States
-
Alkermes, Inc.Terminated
-
Alkermes, Inc.CompletedHealthyUnited States
-
Alkermes, Inc.National Institute on Drug Abuse (NIDA)Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHepatitis CUnited States, Puerto Rico
-
Mural Oncology, IncRecruitingCutaneous Melanoma | Mucosal MelanomaUnited States, Australia, Canada, Italy, Korea, Republic of, Spain, Taiwan, United Kingdom
-
BiogenAlkermes, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Virtually Better, Inc.CompletedHIV/AIDS | Hiv | DisclosureUnited States
-
Mural Oncology, IncCompletedAdvanced Solid TumorsCanada, Spain, United States, Australia, Belgium, Korea, Republic of, Poland
-
Tesaro, Inc.CompletedSolid Tumors | LymphomasUnited Kingdom, United States, Taiwan, Spain, Poland
-
Alkermes, Inc.CompletedOpioid-induced ConstipationUnited States
-
Janssen Research & Development, LLCCompleted
-
Alkermes, Inc.Completed
-
Alios Biopharma Inc.CompletedRespiratory Syncytial Virus InfectionsUnited Kingdom
-
University of CopenhagenNot yet recruiting
-
Alkermes, Inc.CompletedBinge Eating DisorderUnited States
-
Professor Fernando Figueira Integral Medicine InstituteWithdrawnObesity | Preeclampsia | Gestational DiabetesBrazil
-
Astellas Pharma IncOSI PharmaceuticalsCompletedChronic Lymphocytic LeukemiaUnited States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysTerminated
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompleted
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
-
ALK-Abelló A/SCompletedBirch Pollen AllergyFinland, Netherlands
-
Oslo University HospitalCompletedPost Traumatic Stress Symptoms | Post ICU PatientNorway
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompleted
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompletedChronic Lymphocytic LeukemiaUnited States
-
Schiano, Thomas D., MDiTherX Pharmaceuticals Inc.TerminatedHepatitis C InfectionUnited States
-
Alkermes, Inc.CompletedOpioid-induced ConstipationUnited States
-
University of BirminghamNational Institute for Health Research, United Kingdom; University Hospital...CompletedPilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients (ITX5061)Hepatitis C | Evidence of Liver TransplantationUnited Kingdom
-
MedImmune LLCCompletedLupus Erythematosus, SystemicUnited States, Korea, Republic of, Mexico, Peru, Hungary, Ukraine, Czechia, Bulgaria, Colombia, Brazil, Poland, Romania, Taiwan